Sign In
Buy MDWD
$14.12
+0.0200 (+0.142%)
At Close: Jul 31, 2026
MediWound Ltd. (MDWD) Q3 2023 Earnings Call Transcript
01:14pm, Tuesday, 21'st Nov 2023
MediWound Ltd. (NASDAQ:MDWD ) Q3 2023 Earnings Call Transcript November 21, 2023 8:30 AM ET Company Participants Daniel Ferry - LifeSci Advisors Ofer Gonen - Chief Executive Officer Barry Wolfenson -
MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update
07:02am, Tuesday, 21'st Nov 2023
NexoBrid® commercially launched in U.S. and Japan; Company prioritizes operational resources to meet increased global demand
MediWound to Report Third Quarter 2023 Financial Results
08:02am, Tuesday, 14'th Nov 2023
Conference Call and Webcast Scheduled for Tuesday, November 21st at 8:30 am Eastern Time Conference Call and Webcast Scheduled for Tuesday, November 21st at 8:30 am Eastern Time
MediWound (MDWD) Surges 18.2%: Is This an Indication of Further Gains?
09:01am, Friday, 29'th Sep 2023
MediWound (MDWD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase i
MediWound to Participate in Fireside Chat at H.C. Wainwright 25th Annual Global Investment Conference
08:00am, Tuesday, 05'th Sep 2023
YAVNE, Israel, Sept. 05, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today
MediWound (MDWD) Q2 Earnings and Revenues Beat Estimates
06:27pm, Tuesday, 15'th Aug 2023
MediWound (MDWD) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of a loss of $0.41 per share. This compares to loss of $0.91 per share a year ago.
MediWound to Report Second Quarter 2023 Financial Results
08:00am, Monday, 07'th Aug 2023
Conference Call and Webcast Scheduled for Wednesday, August 16th at 8:30 am Eastern Time Conference Call and Webcast Scheduled for Wednesday, August 16th at 8:30 am Eastern Time
3 Micro-Cap Stocks to Buy for Multibagger Returns
06:05am, Tuesday, 11'th Jul 2023
Micro-cap stocks, by definition, are stocks of companies that trade at a valuation range of $50 to $300 million. It goes without saying that investing in micro-cap stocks is a high-risk game.
MediWound to Participate in Fireside Chat at Maxim Group Healthcare Virtual Conference 2023
08:00am, Wednesday, 14'th Jun 2023
YAVNE, Israel, June 14, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today
MediWound: With Expenses Covered, Growth Is Within Reach
07:14pm, Wednesday, 31'st May 2023
MediWound, a company developing medical solutions for skin and burn conditions, is set to begin US distribution of its burn solution NexoBrid in Q3 2023. With a cash pile of over $57 million, the comp
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates
09:25am, Tuesday, 30'th May 2023
MediWound (MDWD) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.84 per share a year ago.
MediWound to Report First Quarter 2023 Financial Results
08:00am, Friday, 12'th May 2023
Conference Call and Webcast Scheduled for Tuesday, May 30th at 8:30 am Eastern Time Conference Call and Webcast Scheduled for Tuesday, May 30th at 8:30 am Eastern Time
MediWound to Present Phase 2 EscharEx® Data at the Symposium on Advanced Wound Care (SAWC) Spring 2023
08:00am, Wednesday, 26'th Apr 2023
Data to be highlighted in oral and poster presentations YAVNE, Israel, April 26, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-ge
MediWound Ltd. (MDWD) Q4 2022 Earnings Call Transcript
02:30pm, Thursday, 16'th Mar 2023
MediWound Ltd. (NASDAQ:MDWD ) Q4 2022 Earnings Conference Call March 16, 2023 8:30 AM ET Company Participants Monique Kosse - LifeSci Advisors, IR Ofer Gonen - Chief Executive Officer Boaz Gur-Lavie -
MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates
09:56am, Thursday, 16'th Mar 2023
MediWound (MDWD) delivered earnings and revenue surprises of -521.05% and 56.79%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
